Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: A case report

American Journal of Critical Care

Volumn 14, Issue 2, 2005, Pages 109-112

  Kyles, Dana M ^a   Baltimore, Jane ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; IMMUNOTHERAPY; LABORATORY TEST; PLASMAPHERESIS; SEPSIS; TREATMENT OUTCOME;

EID: 16244408669     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2005.14.2.109     Document Type: Article

References (13)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
2. Murphy S. Deaths: final data for 1998. In: National Vital Statistics Report. Vol. 48, No. 11. Hyattsville, Md: National Center for Health Statistics; 2000. Dept of Health and Human Services publication 2000-1120 0-0487.
3. Dettenmeier P, Swindell B, Stround M, Arkins N, Howard A. Role of activated protein C in the pathophysiology of severe sepsis. Am J Crit Care. 2003;12:518-524.
4. Sibbald WJ, Clardy P. Investigational and ineffective therapies for sepsis. UpToDate. Available at: www.uptodateonline.com/application/topic/print. asp?file=transfus/6351&type=A&selectedtitle=2~68. Accessed January 13, 2005.
5. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
6. Reeves J. A review of plasma exchange in sepsis. Blood Purif. 2002; 20:282-288.
7. McLeod B. Introduction to the third space issue: clinical applications of therapeutic apheresis. J Clin Apheresis. 2000;15:1-5.
8. Friday J, Kaplan A. Indications for therapeutic plasma exchange. UpToDate. Available at: www.uptodateonline.com/application/topic/print.asp?file= cc_medi/23959&type=A&selectedtitle=6~85. Accessed January 13, 2005.
9. Lee M, Gale R, Yap P. Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiencies. Annu Rev Med. 1999; 37:341-349.
10. Messer G, Meurer M. High-dose intravenous immunoglobulins. In: Burg G, Drummer RG, eds. Strategies for Immunointerventions in Dermatology. New York, NY: Springer-Verlag Telos: 1997:147-159.
11. Werdan K. Supplemental immune globulins in sepsis. Clin Chem Lab Med. 1999;37:341-349.
12. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991;325:110-117.
13. Kress HG, Scheidewig C, Schmitt H, Silber R. Reduced incidence of postoperative infections following intravenous application of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med. 1999;27:1281-1287.